Vis enkel innførsel

dc.contributor.authorHancz, Dora
dc.contributor.authorWesterlund, Elsa
dc.contributor.authorValfridsson, Christine
dc.contributor.authorAemero, Getachew Melkamu
dc.contributor.authorBastiat-Sempe, Benedicte
dc.contributor.authorØrning, Mathias Pontus
dc.contributor.authorLien, Egil
dc.contributor.authorWessels, Michael
dc.contributor.authorPersson, Jenny
dc.date.accessioned2020-02-06T13:36:30Z
dc.date.available2020-02-06T13:36:30Z
dc.date.created2019-08-15T18:17:13Z
dc.date.issued2019
dc.identifier.citationJournal of Innate Immunity. 2019, 1-12.nb_NO
dc.identifier.issn1662-811X
dc.identifier.urihttp://hdl.handle.net/11250/2640074
dc.description.abstractGroup A Streptococcus (GAS) is a common and versatile human pathogen causing a variety of diseases. One of the many virulence factors of GAS is the secreted pore-forming cytotoxin streptolysin O (SLO), which has been ascribed multiple properties, including inflammasome activation leading to release of the potent inflammatory cytokine IL-1β from infected macrophages. IL-1β is synthesized as an inactive pro-form, which is activated intracellularly through proteolytic cleavage. Here, we use a macrophage infection model to show that SLO specifically induces ubiquitination and degradation of pro-IL-1β. Ubiquitination was dependent on SLO being released from the infecting bacterium, and pore formation by SLO was required but not sufficient for the induction of ubiquitination. Our data provide evidence for a novel SLO-mediated mechanism of immune regulation, emphasizing the importance of this pore-forming toxin in bacterial virulence and pathogenesis.nb_NO
dc.language.isoengnb_NO
dc.publisherKargernb_NO
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleStreptolysin O Induces the Ubiquitination and Degradation of Pro-IL-1βnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber1-12nb_NO
dc.source.journalJournal of Innate Immunitynb_NO
dc.identifier.doi10.1159/000496403
dc.identifier.cristin1716294
dc.relation.projectNorges forskningsråd: 223255nb_NO
dc.description.localcode© 2019 The Author(s) Published by S. Karger AG, Basel. This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)nb_NO
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal